Stock listing
OTC:TLTFF Theralase Technologies Inc. Stock
US listing (OTC) of Theralase Technologies Inc. · home listing TSXV:TLT
Follow Theralase Technologies Inc. into a list and get an email when it puts out news.
Share price · OTC:TLTFF
$0.142 USD -0.008 (-5.1%)
Close on Oct 27, 2026
- Day range
- $0.142 – $0.142 USDOct 27, 2026
- Volume
- 6,500 sharesOct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:TLT · Home | $0.195 CAD | +0.015 (+8.3%) | 1,285 | $0.195 | $0.195 | $0.195 | $0.180 | Close on Nov 2, 2026 |
| OTC:TLTFF | $0.142 USD | -0.008 (-5.1%) | 6,500 | $0.142 | $0.142 | $0.142 | $0.150 | Close on Oct 27, 2026 |
| Frankfurt:TTX | €0.116 EUR | -0.001 (-0.9%) | — | €0.116 | €0.116 | €0.116 | €0.117 | Close on Oct 30, 2026 |
| Stuttgart:TTX | €0.123 EUR | -0.003 (-2.4%) | — | €0.119 | €0.123 | €0.114 | €0.126 | Close on Oct 27, 2026 |
- Ticker
- OTC:TLTFF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Theralase Provides Bladder Cancer Clinical Study Update
Latest deck · Oct 22, 2026
Investor Presentation (October 2026)
Investor deck · 16 slides
Latest news
Financings
Private placement of units
Sep 18, 2026
Closed: C$3.56M in the latest tranche · C$0.24 a unit · 1 warrant at C$0.32 · Research Capital Corporation
Dealers: Research Capital Corporation (lead)
Insiders: An aggregate of 116,250 Units, representing gross proceeds of $27,900, were issued to certain insiders of the Company
Use of proceeds: GLP toxicology studies for intravenous Rutherrin in cancers and topical Ruvidar for cold sores; working capital and general corporate purposes
Announced Aug 10, 2026 · Closed Aug 24, 2026 · Closed Aug 28, 2026 · Closed Sep 18, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 16 slides · Oct 22, 2026
Investor Presentation (October 2026)
Investor deck · 16 slides · Oct 15, 2026
Investor Presentation (February 2026)
Investor deck · 21 slides · Feb 17, 2026
Investor Presentation (November 2025)
Investor deck · 20 slides · Nov 14, 2025
Theralase Technologies Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 242 in all · newest Oct 26, 2026 · oldest 2017
- Decks
- 14 decks · latest Oct 22, 2026
Where Theralase Technologies Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:TLT · Home listing | TSXV | Canada | CAD |
| OTC:TLTFF · This page | OTC | United States | USD |
| Cboe Canada:TLT | Cboe Canada | Canada | CAD |
| Lang & Schwarz:A0DLB7 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0DLB7 | LS Exchange | Germany | EUR |
| Frankfurt:TTX | Frankfurt | Germany | EUR |
| Stuttgart:TTX | Stuttgart | Germany | EUR |
| Dusseldorf:TTX | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Theralase Technologies Inc.